Introduction {#s001}
============

S[ystemic lupus erythematosus]{.smallcaps} (SLE) is a complex autoimmune disease with multiple organ injury. SLE is characterized by aberrant T- and B-cell activation, leading to upregulation of autoantibody production and loss of immunological tolerance to self-nuclear antigens. The etiology of SLE is complex and involves the interaction of genetic, epigenetic, environmental, hormonal, and immunoregulatory factors (Tsokos, [@B23]). In recent years, the genes causing SLE have been identified, with more than 40 susceptible loci, by using targeted, genome-wide linkage analysis and, especially, genome-wide association studies (GWASs).

*SLC15A4* (solute carrier family 15, member 4), is a proton-coupled histidine and oligopeptide cotransporter that contains 12 membrane-spanning domains. *SLC15A4* is predominantly transcribed in the brain and immune cells, and especially in plasmacytoid dendritic cells (Yamashita *et al.*, [@B26]; Sasawatari *et al.*, [@B20]; Nakamura *et al.*, [@B18]). Through research with *SLC15A4*-mutant or *SLC15A4*-deficient mice, lack of *SLC15A4* has been linked to impaired nucleotide oligomerization domain-1 (NOD1)-, toll-like receptor 7 (TLR7)-, and TLR9-dependent cytokines such as type 1 interferon (IFN), all of which are indispensable to the pathogenesis of SLE (Sasawatari *et al.*, [@B20]; Baccala *et al.*, [@B1]; Kobayashi *et al.*, [@B12]).

Recent GWASs reported that *SLC15A4* is a lupus-associated locus in both the Chinese and Korean populations (Han *et al.*, [@B8]; Lee *et al.*, [@B13]). A genotype--phenotype analysis indicated that the single-nucleotide polymorphism (SNP) rs10847697 of the gene has a stronger genetic effect on SLE patients with discoid rash in Han Chinese people (He *et al.*, [@B9]). Another group showed that the SNPs rs10847697 and rs1385374 of *SLC15A4* were significantly associated with renal involvement in SLE in Caucasian populations (Wang *et al.*, [@B25]). All of these observations indicate that mutants or polymorphisms of *SLC15A4* have an indispensable role in the pathogenesis of SLE.

To our knowledge, previous studies have focused only on the two SNPs identified from the GWASs. However, the GWASs genotyped hundreds of thousands of tag-SNPs using the Illumina platform, which demands a highly significant *p*-value, and therefore, some SNPs associated with SLE may have been missed.

In the present study, we evaluated associations between *SLC15A4* polymorphisms and SLE in southwestern Han Chinese people through comparisons between 355 SLE patients and 375 healthy individuals. In particular, we focused on the association of alleles and genotypes of 18 SNPs with SLE, and a linkage disequilibrium analysis of these SNPs.

Materials and Methods {#s002}
=====================

The local regional ethics committee approved the study. All participants provided written informed consent.

Patients and controls {#s003}
---------------------

A case--control study was performed with 355 SLE patients (10 men and 345 women, mean age 32.3 ± 12.5 years) and 375 healthy individuals (control group; 18 men and 357 women, mean age 34.0 ± 7.6 years). All subjects were from the Chongqing, Sichuan, Yunnan, or Guizhou areas of southwestern China and are of Han Chinese ethnicity. Patients were recruited from the Department of Dermatology, Southwestern Hospital of the Third Military Medical University (Chongqing, China) from January 2008 to March 2013. All patients with SLE had fulfilled the revised diagnostic criteria of the American College of Rheumatology ([@B11]) and excluded other systematic or autoimmune diseases (Hochberg, [@B11]). Blood samples from the control group were collected at the Medical Examination Center of the same hospital during regular health examinations. All of the healthy individuals were free of history or symptoms of SLE or other autoimmune diseases.

DNA samples and genotyping assays {#s004}
---------------------------------

Venous peripheral blood (2 mL) was collected from each participant with ethylenediaminetetraacetic acid anticoagulant and stored at −80°C until used. Genomic DNA was isolated using a genomic DNA extraction kit (Sangon Biotech) in accordance with the manufacturer\'s instructions.

Eighteen SNPs were selected based on a tagger SNP selection algorithm using the default settings in Haploview 4.2 or associations with SLE that have been reported in previous studies (Han *et al.*, [@B8]). In addition, all SNPs came from the international HapMap project databank for the Han Chinese population of Beijing, China, with a minor allele frequency \>0.05. For genotyping the 18 SNPs with appropriate methods, 16 of the 18 SNPs were detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), with an SNP sequence-specific extension primary added into the polymerase chain reaction (PCR) amplification products (Sangon Biotech). By using a MassARRAY Nanodispenser (Sequenom), the completed genotyping reactions were spotted onto a 384-well SpectroCHIP (Sequenom) and measured using transient (10^−9^ ns) strong laser excitation. Genotype determination was performed in real time with MassARRAY RT software version 3.0.0.4 and analyzed using the MassARRAY Typer software version 3.4 (Sequenom). The genotyping success rate was \>95%.

Genotyping of the remaining two SNPs (rs 7965732, rs 3765108) was performed using TaqMan SNP Genotyping Assays on a LightCycler480 real-time PCR system (Roche). Amplification was performed in a 20-μL reaction volume consisting of 10 μL 2× TaqMan Master Mix, 1 μL 20× Primer and TaqMan Probe (FAM VIC) dye mix, 7 μL ddH~2~O, and 2 μL template DNA. The following thermal cycle conditions were used: prerun at 95°C for 4 min; then denaturation at 95°C for 15 s; and an annealing step at 60°C for 1 min in each of 40 cycles.

Statistical analysis {#s005}
--------------------

Data were analyzed with SPSS software for windows (version 17.0; SPSS). The Hardy--Weinberg equilibrium test was applied to examine the genotype frequency of each SNP, using the exact chi-squared test for both the SLE patients and the healthy controls. Linkage disequilibrium blocks of all SNPs were analyzed with Haploview. Conditional logistic regression analysis was applied to evaluate the independent effect of the associated SNPs. The allele, genotype, and haplotype frequency distributions between the SLE patients and healthy individuals were assessed with the chi-squared test and Fisher\'s exact test. A *post hoc* power analysis was conducted using Power Analysis and Sample Size (PASS) software (NCSS Statistical Software). Estimated odds ratios (ORs) and 95% confidence intervals (CIs) were also calculated based on logistic regression. All the tests were two sided and *p*-values \<0.05 were regarded as significant.

Results {#s006}
=======

Allele frequency distribution of *SLC15A4* polymorphism {#s007}
-------------------------------------------------------

The ages and genders of the patient and control groups were statistically similar. All polymorphic frequencies were confirmed to be in the Hardy--Weinberg equilibrium in both groups.

The distribution of allele frequencies of 5 of the 18 SNPs from *SLC15A4* was significantly different between the groups ([Table 1](#T1){ref-type="table"}). Specifically, the following SNPs were associated with an increased risk of SLE: rs959989 T (OR 1.317, 95% CI 1.027--1.689), rs1385374 T (OR 1.332, 95% CI 1.039--1.707), and rs983492 T (OR 1.295, 95% CI 1.001--1.675). The *post hoc* calculated statistical power of these SNPs (rs959989 T, rs1385374 T, and rs983492 T) was 58.5%, 62.0%, and 51.1%, respectively.

###### 

[Distribution of Allele Frequencies in Single-Nucleotide Polymorphisms of *SLC15A4* in Systemic Lupus Erythematosus Patients and Controls]{.smallcaps}

                   *SLE (*n = *355)*   *Control (*n = 375*)*                                        
  ------------ --- ------------------- ----------------------- ----- ------- ---------------------- ---------------------------------------
  rs7965732    A   642                 90.42                   671   89.47   Reference               
               T   68                  9.57                    79    10.53   0.9 (0.639, 1.266)     0.544
  rs3765108    A   479                 67.46                   512   68.27   Reference               
               G   231                 32.54                   238   31.73   1.037 (0.833, 1.292)   0.743
  rs7308691    A   233                 32.91                   237   31.77   Reference               
               T   475                 67.09                   509   68.23   0.949 (0.762, 1.183)   0.642
  rs7302634    C   307                 43.48                   322   42.93   Reference               
               T   399                 56.52                   428   57.07   0.978 (0.795, 1.203)   0.832
  rs9738216    C   307                 43.36                   321   42.91   Reference               
               T   401                 56.64                   427   57.09   0.982 (0.798, 1.208)   0.863
  rs2291350    C   309                 43.64                   322   42.93   Reference               
               T   399                 56.36                   428   57.07   0.971 (0.790, 1.195)   0.784
  rs11059915   G   546                 76.9                    562   74.93   Reference               
               T   164                 23.1                    188   25.07   0.898 (0.706, 1.142)   0.38
  rs12298615   A   169                 31.35                   147   19.6    Reference               
               G   539                 68.65                   603   80.4    0.778 (0.606, 0.998)   0.048^[a](#tf1){ref-type="table-fn"}^
  rs4760592    C   401                 56.48                   429   57.35   Reference               
               G   309                 43.52                   319   42.65   1.036 (0.842, 1.275)   0.736
  rs959989     A   537                 75.63                   601   80.35   Reference               
               T   173                 24.37                   147   19.65   1.317 (1.027, 1.689)   0.03^[a](#tf1){ref-type="table-fn"}^
  rs959987     C   578                 81.64                   580   77.54   Reference               
               T   130                 18.36                   168   22.46   0.776 (0.601, 1.003)   0.053
  rs7311875    A   537                 76.06                   559   74.53   Reference               
               G   169                 23.94                   191   25.47   0.921 (0.726, 1.169)   0.499
  rs11059925   A   558                 80.64                   593   79.07   Reference               
               C   134                 19.36                   157   20.93   0.907 (0.701, 1.174)   0.458
  rs10847697   A   173                 24.37                   149   19.87   Reference               
               G   537                 75.63                   601   80.13   0.770 (0.600, 0.986)   0.038^[a](#tf1){ref-type="table-fn"}^
  rs1385374    C   536                 75.49                   603   80.4    Reference               
               T   174                 24.51                   147   19.6    1.332 (1.039, 1.707)   0.024^[a](#tf1){ref-type="table-fn"}^
  rs10847699   C   172                 24.36                   192   25.67   Reference               
               T   534                 75.64                   556   74.33   1.072 (0.845, 1.360)   0.566
  rs983492     C   127                 18.46                   170   22.67   Reference               
               T   561                 81.54                   580   77.33   1.295 (1.001, 1.675)   0.049^[a](#tf1){ref-type="table-fn"}^
  rs1552336    C   637                 89.72                   657   87.83   Reference               
               T   73                  10.28                   91    12.17   0.827 (0.597, 1.147)   0.256

Significant association (*p* \< 0.05).

CI, confidence interval; OR, odds ratio; SLE, systemic lupus erythematosus; SNP, single-nucleotide polymorphism.

Associated with a decreased risk of SLE were rs12298615 G (OR 0.778, 95% CI 0.606--0.998) and rs10847697 G (OR 0.770, 95% CI 0.600--0.986). We performed a *post hoc* power analysis and found that the statistical power of rs12298615 G was 50.1% and that of rs10847697 G was 54.3%, with a 5% type-1 error rate.

Genotype frequency distribution of *SLC15A4* polymorphism {#s008}
---------------------------------------------------------

For better understanding the effect of the SNP genotype on the risk of SLE, the genotype distributions of the SLE and control groups were compared using codominant, dominant, and recessive models ([Tables 2--4](#T2 T3 T4){ref-type="table"}, respectively). The results of the codominant model ([Table 2](#T2){ref-type="table"}) indicate that in both the SLE and control groups, the frequency distribution of the AG genotype of rs3765108 was significantly higher than that of the AA genotype (*p* = 0.019, OR 1.447, 95% CI 1.063--1.970), and the frequency distribution of the AT genotype of rs7308691 was significantly higher than that of the AA genotype (*p* = 0.049, OR 1.645, 95% CI 1.000--2.705).

###### 

[Codominant Analysis of Single-Nucleotide Polymorphisms in *SLC15A4* in Systemic Lupus Erythematosus Patients and Controls]{.smallcaps}

                    *SLE (*n = 355*)*   *Control (*n = 375*)*                                        
  ------------ ---- ------------------- ----------------------- ----- ------- ---------------------- ---------------------------------------
  rs7965732    AA   290                 81.69                   302   80.53   Reference               
               TT   3                   0.85                    6     1.6     0.521 (0.129, 2.101)   0.551
               AT   62                  17.46                   67    17.87   0.964 (0.658, 1.411)   0.849
  rs3765108    AA   154                 43.38                   185   49.33   Reference               
               GG   30                  8.45                    48    12.8    0.751 (0.454, 1.243)   0.264
               AG   171                 48.17                   142   37.87   1.447 (1.063, 1.970)   0.019^[a](#tf3){ref-type="table-fn"}^
  rs7308691    AA   33                  9.32                    49    13.14   Reference               
               TT   167                 47.18                   185   49.6    1.340 (0.822, 2.185)   0.239
               AT   154                 43.5                    139   37.27   1.645 (1.000, 2.705)   0.049^[a](#tf3){ref-type="table-fn"}^
  rs7302634    CC   66                  18.7                    76    20.27   Reference               
               TT   112                 31.73                   129   34.4    1.000 (0.660, 1.515)   0.999
               CT   175                 49.58                   170   45.33   1.185 (0.801, 1.753)   0.394
  rs9738216    CC   66                  18.64                   76    20.32   Reference               
               TT   113                 31.92                   129   34.49   1.009 (0.666, 1.528)   0.967
               CT   175                 49.44                   169   45.19   1.192 (0.806, 1.764)   0.378
  rs2291350    CC   67                  18.93                   76    20.27   Reference               
               TT   112                 31.64                   129   34.4    0.985 (0.651, 1.491)   0.942
               CT   175                 49.44                   170   45.33   1.168 (0.790, 1.725)   0.436
  rs11059915   GG   205                 57.75                   212   56.53   Reference               
               TT   14                  3.94                    25    6.67    0.579 (0.293, 1.145)   0.113
               GT   136                 38.31                   138   36.8    1.019 (0.751, 1.382)   0.903
  rs12298615   AA   25                  7.06                    17    45.33   Reference               
               GG   210                 59.32                   245   65.33   0.583 (0.306, 1.109)   0.097
               AG   119                 33.62                   113   30.13   0.716 (0.367, 1.396)   0.326
  rs4760592    CC   112                 31.55                   130   34.76   Reference               
               GG   66                  18.59                   75    20.05   1.021 (0.674, 1.549)   0.92
               CG   177                 49.86                   169   45.19   1.216 (0.875, 1.689)   0.245
  rs959989     AA   208                 48.59                   244   65.24   Reference               
               TT   26                  7.32                    17    4.55    1.794 (0.947, 3.398)   0.07
               AT   121                 34.08                   113   30.22   1.256 (0.916, 1.723)   0.157
  rs959987     CC   237                 66.95                   228   60.96   Reference               
               TT   13                  3.67                    22    5.88    0.568 (0.280, 1.156)   0.115
               CT   104                 29.38                   124   33.16   0.807 (0.587, 1.109)   0.185
  rs7311875    AA   200                 56.66                   211   56.27   Reference               
               GG   16                  4.53                    27    7.2     0.625 (0.327, 1.195)   0.152
               AG   137                 38.81                   137   36.53   1.055 (0.777, 1.432)   0.731
  rs11059925   AA   221                 63.87                   234   62.4    Reference               
               CC   9                   2.6                     16    4.27    0.596 (0.258, 1.376)   0.221
               AC   116                 33.53                   125   33.33   0.983 (0.719, 1.343)   0.912
  rs10847697   AA   26                  7.32                    18    4.8     Reference               
               GG   208                 58.59                   244   65.07   0.590 (0.315, 1.107)   0.097
               AG   121                 34.08                   113   30.13   0.741 (0.386, 1.425)   0.368
  rs1385374    CC   207                 58.31                   246   65.6    Reference               
               TT   26                  7.32                    18    4.8     1.717 (0915, 3.219)    0.089
               CT   122                 34.37                   111   29.6    1.306 (0.952, 1.793)   0.098
  rs10847699   CC   17                  4.82                    28    7.49    Reference               
               TT   198                 56.09                   210   56.15   1.553 (0.824, 2.925)   0.17
               CT   138                 39.09                   136   36.36   1.671 (0.875, 3.193)   0.117
  rs983492     CC   13                  3.78                    23    6.13    Reference               
               TT   230                 66.86                   228   60.8    1.785 (0.882, 3.610)   0.103
               CT   101                 29.36                   124   33.07   1.441 (0.695, 2.988)   0.324
  rs1552336    CC   287                 80.85                   287   76.74   Reference               
               TT   5                   1.41                    4     1.07    1.250 (0.332, 4.702)   1
               CT   63                  17.75                   83    22.2    0.759 (0.526, 2.095)   0.139

Significant association (*p* \< 0.05).

###### 

[Dominant Analysis of Single-Nucleotide Polymorphisms in *SLC15A4* in Systemic Lupus Erythematosus Patients and Controls]{.smallcaps}

                       *SLE (*n = 355*)*   *Control (*n = 375*)*                                         
  ------------ ------- ------------------- ----------------------- ----- ------- ----------------------- ---------------------------------------
  rs7965732    TT+AT   65                  18.31                   73    19.47   0.927 (0.640, 1.344)    0.69
               AA      290                 81.69                   302   80.53   Reference                
  rs3765108    GG+AG   201                 56.62                   190   50.67   1.271 (0.949, 1.701)    0.107
               AA      154                 43.38                   185   49.33   Reference                
  rs7308691    TT+AT   321                 90.68                   324   86.86   1.471 (0.922, 2.348)    0.104
               AA      33                  9.32                    49    13.14   Reference                
  rs7302634    TT+CT   287                 81.3                    299   79.73   1.105 (0.765, 1.596)    0.593
               CC      66                  18.7                    76    20.27   Reference                
  rs9738216    TT+CT   288                 81.36                   298   79.68   1.113 (0.771, 1.607)    0.568
               CC      66                  18.64                   76    20.32   Reference                
  rs2291350    TT+CT   287                 81.07                   299   79.73   1.089 (0.755, 1.570)    0.649
               CC      67                  18.93                   76    20.27   Reference                
  rs11059915   TT+GT   150                 42.25                   163   43.47   0.952 (0.710, 1.276)    0.741
               GG      205                 57.75                   212   56.53   Reference                
  rs12298615   GG+AG   329                 92.94                   358   95.47   0.625 (0.331, 1.178)    0.143
               AA      25                  7.06                    17    4.53    Reference                
  rs4760592    GG+CG   243                 68.45                   244   65.24   1.156 (0.849, 1.574)    0.358
               CC      112                 31.55                   130   34.76   Reference                
  rs959989     TT+AT   147                 41.41                   130   34.76   1.326 (0.983, 1.790)    0.065
               AA      208                 58.59                   244   65.24   Reference                
  rs959987     TT+CT   117                 33.05                   146   39.04   0.771 (0.569, 1.044)    0.093
               CC      237                 66.95                   228   60.96   Reference                
  rs7311875    GG+AG   153                 43.34                   164   43.73   0.984 (0.734, 1.320)    0.915
               AA      200                 56.66                   211   56.27   Reference                
  rs11059925   CC+AC   125                 36.13                   141   37.6    0.939 (0.693, 1.271)    0.682
               AA      221                 63.87                   234   62.4    Reference                
  rs10847697   GG+AG   329                 92.68                   357   95.2    0.638 (0.343, 1.185)    0.152
               AA      26                  7.32                    18    4.8     Reference                
  rs1385374    TT+CT   148                 41.69                   129   34.4    1.1363 (1.010, 1.840)   0.042^[a](#tf4){ref-type="table-fn"}^
               CC      207                 58.31                   246   65.6    Reference                
  rs10847699   TT+CT   336                 95.18                   346   92.51   1.599 (0.860, 2.976)    0.135
               CC      17                  4.82                    28    7.49    Reference                
  rs983492     TT+CT   331                 96.22                   352   93.87   1.664 (0.829, 3.338)    0.148
               CC      13                  3.78                    23    6.13    Reference                
  rs1552336    TT+CT   68                  19.15                   87    23.26   0.782 (0.547, 1.117)    0.176
               CC      287                 80.85                   287   76.74   Reference                

Significant association (*p* \< 0.05).

###### 

[Recessive Analysis of Single-Nucleotide Polymorphisms in *SLC15A4* in Systemic Lupus Erythematosus Patients and Controls]{.smallcaps}

                       *SLE (*n = 355*)*   *Control (*n = 375*)*                                        
  ------------ ------- ------------------- ----------------------- ----- ------- ---------------------- -------
  rs7965732    TT      3                   0.85                    6     1.6     0.524 (1.3, 2.112)     0.556
               AA+AT   352                 99.15                   369   98.4    Reference               
  rs3765108    GG      30                  8.45                    48    12.8    0.629 (0.389, 1.018)   0.057
               AA+AG   325                 91.55                   327   82.7    Reference               
  rs7308691    TT      167                 47.18                   185   49.6    0.908 (0.678, 1.214)   0.514
               AA+AT   187                 52.82                   188   50.4    Reference               
  rs7302634    TT      112                 31.73                   129   34.4    0.886 (0.65, 1.207)    0.444
               CC+CT   241                 68.27                   246   65.6    Reference               
  rs9738216    TT      113                 31.92                   129   34.49   0.891 (0.654, 1.213)   0.462
               CC+CT   241                 68.08                   245   65.51   Reference               
  rs2291350    TT      112                 31.64                   129   34.4    0.883 (0.648, 1.202)   0.428
               CC+CT   242                 68.36                   246   65.6    Reference               
  rs11059915   TT      14                  3.94                    25    6.67    0.575 (0.294, 1.124)   0.102
               GG+GT   341                 96.06                   350   93.33   Reference               
  rs12298615   GG      210                 59.32                   245   65.33   0.774 (0.573, 1.045)   0.094
               AA+AG   144                 40.68                   130   34.66   Reference               
  rs4760592    GG      66                  18.59                   75    20.05   0.910 (0.630, 1.316)   0.617
               CC+CG   289                 81.41                   299   79.95   Reference               
  rs959989     TT      26                  7.32                    17    4.55    1.660 (0.884, 3.114)   0.111
               AA+AT   329                 92.68                   357   95.45   Reference               
  rs959987     TT      13                  3.67                    22    5.88    0.610 (0.302, 1.230)   0.167
               CC+CT   341                 96.33                   352   94.12   Reference               
  rs7311875    GG      16                  4.53                    27    7.2     0.612 (0.324, 1.156)   0.127
               AA+AG   337                 95.47                   348   92.8    Reference               
  rs11059925   CC      9                   2.6                     16    4.27    0.599 (0.261, 1.374)   0.222
               AA+AC   337                 97.4                    359   95.73   Reference               
  rs10847697   GG      208                 58.59                   244   65.07   0.760 (0.563, 1.025)   0.072
               AA+AG   147                 41.41                   131   34.93   Reference               
  rs1385374    TT      26                  7.32                    18    4.8     1.567 (0.844, 2.912)   0.152
               CC+CT   329                 92.68                   357   95.2    Reference               
  rs10847699   TT      198                 56.09                   210   56.15   0.998 (0.744, 1.337)   0.987
               CC+CT   155                 43.91                   164   43.85   Reference               
  rs983492     TT      230                 66.86                   228   60.8    1.301 (0.958, 1.766)   0.091
               CC+CT   114                 33.14                   147   39.2    Reference               
  rs1552336    TT      5                   1.41                    4     1.07    1.321 (0.352, 4.961)   0.937
               CC+CT   350                 98.59                   370   98.93   Reference               

According to the analysis using the dominate model ([Table 3](#T3){ref-type="table"}), only one SNP (rs1385374, TT+CT cf.CC, *p* = 0.042, OR 1.1363, 95% CI 1.010--1.840) was significantly associated with increased risk of SLE. According to the analysis results of the recessive model, there were no significant differences among the 18 SNP genotypes ([Table 4](#T4){ref-type="table"}).

Linkage disequilibrium analysis {#s009}
-------------------------------

To confirm that the five detected SNPs (rs959989, rs1385374, rs983492, rs12298615, and rs10847697) are independent, we performed a conditional analysis ([Table 5](#T5){ref-type="table"}). However, the analysis showed complete abrogation of genetic associations among the five SNPs. This may be due to the relatively high *p-*value before the analysis, due to the small sample size. We found that the association of rs959989 and rs983492 was slightly attenuated, while associations among rs12298615, rs10847697, and rs138537 were markedly attenuated when adjusted for each other ([Table 5](#T5){ref-type="table"}). In addition, using Haploview, the four SNPs rs12298615, rs959989, rs10847697, and rs138537 are in near absolute linkage disequilibrium (r^2^ \> 0.98). Thus, we chose rs959989 from the four SNPs and rs983492 to perform a linkage disequilibrium analysis. Future studies with a large sample are warranted. We also note that other variants not assessed in this study are possible and might contribute to this effect.

###### 

[Conditional Logistic Regression Analysis of *SLC15A4* Single-Nucleotide Polymorphisms Associated with Systemic Lupus Erythematosus]{.smallcaps}

                       p*~adjusted~ when conditioned on:*                           
  ------------ ------- ------------------------------------ ------- ------- ------- -------
  rs12298165   0.056   N/A                                  0.738   0.874   0.355   0.129
  rs959989     0.036   0.146                                N/A     0.109   0.136   0.101
  rs10847697   0.045   0.895                                0.99    N/A     0.99    0.124
  rs1385374    0.029   0.222                                0.313   0.99    N/A     0.085
  rs983492     0.055   0.16                                 0.155   0.155   0.172   N/A

*p-*Value, calculated by logistic regression analysis under the additive model.

N/A, not applicable.

Next, we performed linkage disequilibrium with the two SNPs rs959989 and rs983492 by using Haploview ([Fig. 1](#f1){ref-type="fig"}). [Table 6](#T6){ref-type="table"} shows the frequencies of different haplotypes and the results from the analysis of the association with SLE. The prevalence of the haplotype TA was significantly higher in the SLE patients than in the control group (*p* = 0.024, OR 1.333, 95% CI 1.039--1.125).

![Analysis of linkage disequilibrium of two single-nucleotide polymorphisms in *SLC15A4* in systemic lupus erythematosus patients and controls. The haplotype block structure was analyzed using Haploview software, version 4.2. Each box gives the coefficient of determination (*r*^2^), and the *r*^2^ color scheme is as follows: *white* (*r*^2^ = 0), *gray* (0 \< *r*^2^ \< 1), *black* (*r*^2^ = 1).](fig-1){#f1}

###### 

[Haplotype Analysis in Systemic Lupus Erythematosus Patients and Controls]{.smallcaps}

  *Haplotype*   *Total (%)*   *Case (%)*   *Control (%)*   p                                       *OR (95% CI)*
  ------------- ------------- ------------ --------------- --------------------------------------- ----------------------
  AT            840 (57.5)    406 (57.2)   434 (57.9)      0.792                                   0.972 (0.790--1.197)
  TA            318 (21.8)    173 (24.4)   146 (19.5)      0.024^[a](#tf7){ref-type="table-fn"}^   1.333 (1.039--1.125)
  AC            299 (20.5)    131 (18.5)   168 (22.4)      0.062                                   0.784 (0.607--1.012)

Significant association (*p* \< 0.05).

Discussion {#s010}
==========

In this study, we investigated 18 SNPs in the *SLC15A4* gene with a case--control study and found that five SNPs (rs959989, rs1385374, rs983492, rs12298615, and rs10847697) were associated with SLE in this Han Chinese population. Using a codominant model for analysis, we found that the frequencies of the rs3765108 AG genotype and the rs7308691 AT genotype were significantly higher in the SLE patients, suggesting that these SNPs may be a risk factor for SLE. Moreover, by using the dominant model, the results suggest that rs1385374 (TT+CT cf. CC) was associated with increased risk of SLE. In addition, one *SLC15A4* haplotype was also associated with SLE.

SLE is a systemic autoimmune disease accompanied by auto-antibodies, including anti-DNA and anti-small nuclear ribonucleoprotein (snRNP) antibodies, which lead to multiple organ damage (Liu and Davidson, [@B15]). Nucleic acid binding receptors such as TLR7 and TLR9 are crucial in SLE, promoting the production of IFN-1 through plasmacytoid dendritic cells and activating autoreactive B cells (Cao *et al.*, [@B4]; Green and Marshak-Rothstein, [@B7]). Moreover, TLR7 and IFN-α can act together and induce the switching of B cells to IgG2a/c during influenza infection (Marshak-Rothstein, [@B16]; Heer *et al.*, [@B10]). On the contrary, *SLC15A4* was found to be required for the production of antibodies in B cells in a mouse model of lupus, and the lack of *SLC15A4* in B cells led to reduced production of IgG2a and IgG2c auto-antibodies such as anti-snRNP and anti-DNA antibodies (Kobayashi *et al.*, [@B12]). Interestingly, Dosenovic *et al.* (Dosenovic *et al.*, [@B6]) demonstrated that a functional *SLC15A4* was required for effective antibody isotype switching to IgG2c, in response to TLR9 stimulation.

Previous studies (Lee *et al.*, [@B14]; Blasius *et al.*, [@B2]; Sasawatari *et al.*, [@B20]; Baccala *et al.*, [@B1]) reported that *SLC15A4* has a role in maintaining the appropriate endosomal pH and is necessary for the innate immune response triggered by NOD1, NOD2, TLR7, and TLR9. In a feeble mouse model, defective *SLC15A4* led to chronic viral infection by reducing the function of plasmacytoid dendritic cells (Blasius *et al.*, [@B3]). Previous studies showed that synonymous mutants can affect splicing events, messenger RNA stability, microRNA binding, nucleosome formation, and genes\' translational efficiency, sometimes even causing disorders (Chamary *et al.*, [@B5]; Plotkin and Kudla, [@B19]; Waldman *et al.*, [@B24]). In our study, we found a significantly lower risk of SLE associated with the SNP rs10847697, a synonymous polymorphism that has been reported associated with discoid rash or renal disorder (He *et al.*, [@B9]; Wang *et al.*, [@B25]). Therefore, this will give us a new research direction to investigate the influence of rs10847697 on the function of *SLC15A4*. The others four SNPs, however, are all located in the intron region and it is hard to investigate their functional studies.

The first GWAS regarding *SLC15A4* showed that it is closely associated with type 2 diabetes in Japan (Takeuchi *et al.*, [@B22]). Subsequently, another GWAS by Han *et al.* reported that *SLC15A4* is a new susceptibility gene for SLE and identified two SNPs (rs10847697, rs1385374) associated with SLE in a Chinese population. This is in agreement with our results. In addition, several other research projects revealed that many clinical features were associated with the two SNPs (He *et al.*, [@B9]; Wang *et al.*, [@B25]; Zuo *et al.*, [@B27]).

Interestingly, a recent study identified new risk loci associated with SLE, using high-density genotyping based on the Immunochip SNP microarray, in Asian ancestry (Sun *et al.*, [@B21]). In their research, five SNPs (rs959989, rs1385374, rs983492, rs12298615, and rs10847697) were detected and are generally consistent with our results, except rs983492. We speculate that this difference may be due to different detection methods and racial constitution. Further studies with larger sample sizes are needed to confirm this hypothesis.

The present study is limited in that the *p-*values reflected much less significance compared with previous studies, and no significant difference was indicated after the Bonferroni correction or through the Benjamini--Hochberg method. This may be due to the relatively small sample size of our study (hundreds), compared with previous studies (thousands), which limited statistical power. It also must be noted that patients of other ethnicities may have greater differences in allele frequencies (Mori *et al.*, [@B17]) than our Han Chinese population. Therefore, our results may not be applicable to other populations. Functional studies of the identified SNPs are warranted, and we are planning a future investigation of the expression and 3′-untranslated region of the gene using microRNAs *in vitro*.

The pathogenesis of SLE is believed to involve the combined effects of a large number of minor genes, and one of these is *SLC15A4*. Our study provides clues that help elucidate the role of the *SLC15A4* gene in the pathogenesis of SLE in Han Chinese people. More comprehensive research that includes populations of different ethnicities is warranted. Further studies should focus on the physiological functions of the mutated loci that occur with significantly different frequencies between SLE and healthy individuals, as well as the influence of SNPs in *SLC15A4* on SLE in the Han Chinese population.
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